Eli Lilly & Co. (NYSE:LLY)

Major Pharma Sees Fading Short Interest

Posted: January 11, 2019 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Are Loxo Shareholders Getting Enough in the Buyout?

Posted: January 7, 2019 at 11:05 am

Loxo Oncology Inc. (NASDAQ: LOXO) shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly and Co. (NYSE: LLY). The ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Posted: December 27, 2018 at 10:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Altbaba, AutoDesk, AutoZone, CBS, Eli Lilly, Lululemon, Michael’s, Target and More

Posted: December 27, 2018 at 9:15 am

The futures traded down big on Thursday morning but were off the lows as investors digest the massive record Wednesday rally on Wall Street. Incredible retail numbers were posted on ...
Read Full Story »

Eli Lilly Scores Solid Results in Psoriatic Arthritis Study

Posted: December 17, 2018 at 10:10 am

Eli Lilly and Co. (NYSE: LLY) has announced positive results from its late-stage active psoriatic arthritis (PsA) study. This trial is the first completed large head-to-head superiority study in active ...
Read Full Story »

Eli Lilly Receives Crucial FDA Update on Lupus Study

Posted: December 13, 2018 at 10:15 am

The U.S. Food and Drug Administration (FDA) has granted a Fast Track designation to Eli Lilly and Co.'s (NYSE: LLY) baricitinib, which is being studied for the treatment of systemic lupus ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Posted: December 12, 2018 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Posted: November 28, 2018 at 9:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Eagle, Eli Lilly, GameStop, Intuit, Novavax, Nvidia, Salesforce, Schlumberger and More

Posted: November 26, 2018 at 8:40 am

Stocks were looking to open higher on Monday after the worst Thanksgiving trading week in seven years. Investors have been forced to see numerous waves of selling in 2018, and ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Posted: November 12, 2018 at 10:10 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

Posted: November 8, 2018 at 12:45 pm

The treatment of erectile dysfunction (ED) has helped literally tens of millions of men in America alone. The number of drugs treating ED has grown substantially over the years, and ...
Read Full Story »

Eli Lilly Dips Despite Solid Q3 Results

Posted: November 6, 2018 at 10:20 am

Eli Lilly and Co. (NYSE: LLY) released its third-quarter financial results before the markets opened on Tuesday. The pharma giant said that it had $1.39 in earnings per share (EPS) ...
Read Full Story »

What to Watch For When Eli Lilly Reports Tuesday Morning

Posted: November 5, 2018 at 11:25 am

Eli Lilly and Co. (NYSE: LLY) is scheduled to release its most recent quarterly results before the markets open on Tuesday. Consensus estimates from Thomson Reuters are calling for $1.35 ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aetna, Baker Hughes, Chesapeake Energy, Cognizant, Cummins, Eli Lilly, GE, Qualcomm, Weatherford and More

Posted: October 31, 2018 at 9:05 am

Stocks were indicated to open much higher on Wednesday after Tuesday's bounce, and earnings may be saving the day, on top of a strong ADP payrolls report. Some investors have ...
Read Full Story »

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Posted: October 29, 2018 at 9:45 am

Dicerna Pharmaceuticals Inc. (NASDAQ: DRNA) and Eli Lilly and Co. (NYSE: LLY) are partnering up in a global licensing and research collaboration focused on the discovery, development and commercialization of ...
Read Full Story »